New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
07:51 EDTFOLDAmicus Theraputics sees FY13 cash spend $52M-$58M
Cash, cash equivalents, and marketable securities totaled $99.1M at December 31, 2012 compared to $55.7M at December 31, 2011. Amicus expects FY13 net cash spend between $52M-$58M. The current cash position and anticipated Fabry program reimbursements from GSK are projected to fund operations into the second half of 2014.
News For FOLD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
14:10 EDTFOLDGlaxoSmithKline liquidates passive stake in Amicus Therapeutics
Subscribe for More Information
09:37 EDTFOLDActive equity options trading
Subscribe for More Information
08:59 EDTFOLDAmicus Therapeutics 11.32M share Block Trade priced at $5.40
Subscribe for More Information
October 20, 2014
07:10 EDTFOLDAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 19, 2014
19:46 EDTFOLDAmicus announces additional positive data from from Fabry monotherapy study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use